» Articles » PMID: 28665463

Port in Oncology Practice: 3-monthly Locking with Normal Saline for Catheter Maintenance, a Preliminary Report

Overview
Journal J Vasc Access
Publisher Sage Publications
Date 2017 Jul 1
PMID 28665463
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Patients with cancer need stable venous access using central vascular devices like central venous ports and peripherally inserted central catheters that can be used for a wide range of indications. Numerous flushing protocols exist including different frequencies for catheter locking to maintain catheter patency. The aim of this retrospective study was to evaluate the incidence of lumen occlusion of central venous ports in a group of adult cancer patients, adopting a policy of locking with normal saline every three months.

Methods: This is a single-center retrospective observational study. During follow-up, we analyzed adult cancer patients who had undergone port insertion from January 1st, 2007 to August 31st, 2014. Flushing and locking were performed every three months with a syringe containing normal saline.

Results: We collected data from 381 patients with ports inserted in subclavian vein (379 patients) and in the right jugular vein (2 patients). Locking was performed during 3-monthly follow-up visits. Median follow-up was 810 days (90-2700 days). Among 381 ports, 59 were removed; the reasons for removal were: end of use (45 cases), catheter rupture (9 cases), dislocation (3 cases) and catheter-related bloodstream infection (2 cases). We had no reports of lumen occlusion.

Conclusions: Our data suggest that locking ports with normal saline every three months is not associated with an increased risk of lumen occlusion.

Citing Articles

Is it feasible to prolong the flushing interval for totally implantable venous access devices (TIVADs)? A systematic review and meta-analysis.

Liu L, Liang J, Liu Z, Jin Y, Ma C, Zhao X Int J Clin Oncol. 2024; 30(1):40-50.

PMID: 39601969 DOI: 10.1007/s10147-024-02665-2.


Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.

Curtis K, Gough K, Krishnasamy M, Tarasenko E, Hill G, Keogh S BMC Cancer. 2024; 24(1):498.

PMID: 38641574 PMC: 11027380. DOI: 10.1186/s12885-024-12099-8.


Expert consensus on the clinical application of totally implantable venous access devices in the upper arm (2022 Edition).

Qiu X, Jin G, Zhang X, Xu L, Ding J, Li W J Interv Med. 2023; 6(2):53-58.

PMID: 37409058 PMC: 10318320. DOI: 10.1016/j.jimed.2023.04.005.


Impact of central venous port implantation method and access choice on outcomes.

Erdemir A, Rasa H World J Clin Cases. 2023; 11(1):116-126.

PMID: 36687176 PMC: 9846971. DOI: 10.12998/wjcc.v11.i1.116.


Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast cancer.

Wang Y, Tian H, Chen X, Zhang J, Wang L, Fan H Front Oncol. 2022; 12:1021488.

PMID: 36531077 PMC: 9755344. DOI: 10.3389/fonc.2022.1021488.